LONDON — Britain’s state-run National Health Service will on Monday begin the world’s biggest trial of Grail Inc’s flagship Galleri blood test that can be used to detect more than 50 types of cancer before symptoms appear. Read More
Toronto Sports News Continuously Updated
Leave a Reply